Shared Content Block:
Styles -- retool bulleted and numbered lists, add "spaced-out" class
The mission of the RNA Bioscience Initiative (RBI) is to cultivate a vibrant center of discovery and innovation in RNA biology, informatics, diagnostics, and therapy. Our goal is to provide a fluid pipeline from basic to clinical RNA research at the Anschutz Medical Campus.
The RNA Bioscience Initiative was started in January 2016 with $20 million in funding from the Dean’s Office of the University of Colorado School of Medicine. The program’s first director, Richard Davis, PhD, in collaboration with then associate directors David Bentley, PhD and Jay Hesselberth, PhD, quickly established a system of support and programming to expand RNA-focused research on the CU Anschutz campus. In addition, they recruited five new faculty– all young, rising stars in the field of RNA biology; and reconnected to the RNA community at CU Boulder, which includes foundational RNA researchers Thomas Cech (Nobel Prize, 1989), Roy Parker (HHMI Investigator, Director BioFrontiers Institute) and many others. These first moves re-energized local and regional interest in RNA biology and lead to the establishment of the RBI as a nationally recognized, cutting-edge hub for RNA research.
Since its inception in January 2016 the RBI has: